Search Results 1571-1580 of 14775 for anti-TNF drugs

1. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

   ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

2. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

   It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...

3. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   ... therapy; or arthritis that is managed without systemic therapy beyond oral acetaminophen and nonsteroidal anti-inflammatory drugs) * Have any condition ...

4. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

   The antibody is used to recognize tumor cells so the anti-cancer drug can kill them. Participation eligibility. Participant eligibility includes age, gender, ...

5. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index - Mayo Clinic

   An algorithm for a CTC-Endocrine Therapy Index (CTC-ETI) has been constructed that can be calculated for each patient using the CTC enumeration and marker ...

6. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

   * Prior treatment with any adoptive T-cell therapy or anti-ROR1 therapy * Prior solid organ transplantation * Active, untreated brain metastasis or ...

7. Mayo Clinic researchers study new class of drugs to treat multiple myeloma

   She says that bispecific antibodies represent a new class of immunotherapy drugs based on similar technology as CAR-T cell therapy, but it uses off-the-shelf ...

8. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

   Systemic anti-lymphoma therapy within 28 days or use of antibody agents within 8 weeks use of radioimmunotherapy within 3 months; Known seropositive for or ...

9. Anabolic Steroid (Oral Route, Parenteral Route) Before Using - Mayo Clinic

   It is not known whether anabolic steroids pass into breast milk. Drug Interactions. Although certain medicines should not be used together at all, in other ...

10. Bictegravir, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Biktarvy. Descriptions. Bictegravir, emtricitabine ...